Yameng Cui
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 1
- Angiogenesis and VEGF in Cancer 1
- Epigenetics and DNA Methylation 1
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Wei Zhao (4 shared papers)Jingwen Liu (4 shared papers)Lina Liu (3 shared papers)Jie Wu (3 shared papers)Xiaoqian Qi (2 shared papers)Shiqing Ma (2 shared papers)Anan Huang (5 shared papers)Xiaozhou Ma (3 shared papers)
- Journals
- Frontiers in Pharmacology (1 paper)Cell Death and Differentiation (1 paper)Phytomedicine (1 paper)Biological Procedures Online (1 paper)Cancer Gene Therapy (1 paper)
- Partner nations
- China
In The Last Decade
Yameng Cui
15 papers receiving 663 citations
Yameng Cui's Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 276
- Molecular Biology 465
- Geriatrics and Gerontology 12
- Cardiology and Cardiovascular Medicine 58
- Immunology 52
Countries citing papers authored by Yameng Cui
This map shows the geographic impact of Yameng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yameng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yameng Cui more than expected).
Fields of papers citing papers by Yameng Cui
This network shows the impact of papers produced by Yameng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yameng Cui. The network helps show where Yameng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yameng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 179 | |
| 2 | 2020 | 152 | |
| 3 | 2018 | 64 | |
| 4 | 2018 | 46 | |
| 5 | 2022 | 43 | |
| 6 | 2022 | 36 | |
| 7 | 2019 | 30 | |
| 8 | 2018 | 27 | |
| 9 | 2020 | 25 | |
| 10 | Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment Hit paper breakdown → | 2025 | 23 |
| 11 | 2022 | 18 | |
| 12 | 2020 | 12 | |
| 13 | 2024 | 7 | |
| 14 | Relationship between circulating concentration of Ang II, ADM and ADT and left ventricular hypertrophy in hypertension. | 2019 | 2 |
| 15 | 2025 | 2 | |
| 16 | 2026 | 0 | |
| 17 | 2026 | 0 |
About Yameng Cui
Yameng Cui is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Pharmacology, having authored 17 papers that have together received 666 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Cardiovascular Function and Risk Factors (2 papers), Extracellular vesicles in disease (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Cancer Research (276 citations), Molecular Biology (465 citations), Geriatrics and Gerontology (12 citations), Cardiology and Cardiovascular Medicine (58 citations) and Immunology (52 citations). Yameng Cui has collaborated with scholars based in China. Frequent co-authors include Wei Zhao, Jingwen Liu, Lina Liu, Jie Wu, Xiaoqian Qi, Shiqing Ma, Anan Huang, Xiaozhou Ma, Xin Hu and Zihao Liu. Their work appears in journals such as Frontiers in Pharmacology, Cell Death and Differentiation, Phytomedicine, Biological Procedures Online and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.